Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Allergan's novel glaucoma drug nears clinical trials

Nov. 2, 2000

Update on Pharmacia's ocular medications

Oct. 24, 2000

Protective effect demonstrated for SKK-60060 in rat model of retinal ischemia-reperfusion

Oct. 23, 2000

Ciba Vision and QLT seek to expand Visudyne indication in the E.U.

Oct. 5, 2000

New series from Senju particularly useful for ocular disorders

Oct. 4, 2000

New ocular hypotensive agents in the Alcon pipeline

Sep. 8, 2000

New agents for glaucoma reported by Santen

Sep. 4, 2000

Visudyne sNDA granted priority review status

Sep. 1, 2000

Inspire reports synthesis of more stable P2Y2 agonists

Aug. 30, 2000

Allergan in-licenses gatifloxacin from Kyorin for treatment of ocular infections

Aug. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...